AROI-ESTRO GYN Teaching Course
What do we know about dose to pathological nodes?
Nodal recurrence in pathological nodes after boost
Ramlov et al, Acta Oncol, 2015: limited dose effect for pathological nodes (~55- 65Gy boosts)
Pittsburgh, IJROBP 2015:
0% after boost dose of 55Gy
EMBRACE I:
8% at median FUP of 2 years in patients boosted with a median dose of 59Gy
7
Made with FlippingBook